Calendar Links
This Week
MM/YY – MM/YY
NEWS EVENTS
EVENTS
2021-2022 Interdisciplinary Research Seminar Schedule
All seminars will be held at noon at the Gordon Center for Integrative Science W301.
Date | Speaker | Institution |
10/5/21 | David Pincus | UChicago |
10/19/21 | Yi Liao [Rust Lab postdoc] | UChicago |
10/26/21 | Bozhi Tian (chalk talk) | UChicago |
11/2/21 | Seppe Kuehn | UChicago |
11/16/21 | Tong Wu [He Lab postdoc] | UChicago |
11/23/21 | Thanksgiving break | UChicago |
11/30/21 | Yamuna Krishnan | UChicago |
12/7/21 | Grier prize finalists presentation | |
1/11/22 | Kevin Welsher. Duke Univ [Virtual Presentation] | |
1/25/22 | Alexandra Zidovska | NYU [Virtual Presentation] |
2/24/22 | Mara Prentiss | Harvard University |
3/8/22 | Shankar Mukherji | Wash Univ St. Louis |
3/15/22 | Rae Anderson | USD |
3/22/22 | Edouard Hannezo | IST Austria |
3/22/22 | Mikhail Shapiro | Cal Tech |
3/29/22 | Lisa Jones | Univ Maryland |
4/5/22 | Ahmad Khalil | Boston Univ |
4/19/22 | Mike Levin | Tufts Univ [Virtual Presentation] |
4/26/22 | Tom Kirchhausen | Harvard Univ |
5/3/22 | Jin Zhang | UCSD |
5/24/22 | Suri Vaikuntanathan | UChicago |
10/18/22 | Sri Iyer Biswas | Purdue Univ |
2022 Seitz Lecture: Wendell Lim (UCSF)| April 15
Wendell Lim will be the 2022 Frederick Seitz Lecture speaker, visiting on April 15, 2022. Prof. Lim is the Chair of Cellular and Molecular Pharmacology at University of California, San Francisco. He is the Director of the UCSF Center for Synthetic Immunology.
Abstract: Instead of taking apart and characterizing molecular components involved in naturally existing biological processes, the emerging field of synthetic biology focuses on the inverse goal of building or programing complex living systems from simpler molecular components. This novel design perspective offers several unique features. First, it allows us to systematically explore the principles governing biological systems design, in a manner independent from the biases of natural history. Second, understanding these principles should enable the engineering of novel cellular behaviors that, although non-natural, are therapeutically useful and as precise as evolved systems. For example, we are genetically reprogramming immune cells, using engineered sensors and circuits, to precisely traffic to, identify, and disrupt disease tissues, in cases such as cancer or autoimmune disorders. We are also exploring how to reprogram cells to self-assemble into user-specified tissues. This work reveals the remarkable functional plasticity of cellular machines, and lays the groundwork for creating revolutionary living cell therapies that exceed traditional molecular therapeutics in their ability to address some of our most challenging diseases.
Zoom link: https://uchicago.zoom.us/j/94981013029?pwd=MlN6OCtTZ2pSbm5BMTdzUFNKZitZZz09